In this review
Ask what happens between prescription refills
The current weight-care offer describes online consultation, medication, syringes and alcohol pads, educational access and ongoing provider support. That gives a reader concrete inclusions to compare. It does not establish private dietitian appointments, scheduled coaching sessions, an immediate clinical reply or a complete prepaid laboratory panel. I would ask who helps if eating becomes difficult and how a concern reaches the prescriber. [1]
The FAQ describes medical review within 24 hours, with live chat or video required in some states. Treat that as a stated review expectation rather than guaranteed acceptance or delivery. Eligibility and availability vary by therapy and location. A general promise of ongoing support should be translated into an actual follow-up arrangement before choosing a long term. [2]
Carry the full selected commitment into the comparison
Semaglutide is listed at $190 for one month, $399 for three, $714 for six and $1,188 for twelve. Tirzepatide costs $239, $589, $1,074 and $1,788 for those selections. The cost planner can compare the full amounts due over the same period. Each plan renews at its listed interval. The lowest $99 and $149 monthly equivalents are therefore part of twelve-month commitments, not flexible one-month bills. [1]
FAQ says medication is billed when shipped. The product’s four-week medication label remains on longer selections, so obtain the actual dispensing schedule and complete supplied preparation. Neither the number of months billed nor a representative vial image establishes concentration, vial count or how much arrives in the first parcel. If you are also considering TMates’ longer plans, ask both providers what is due at enrollment and how much medicine arrives in the first shipment. [1] [2]
Clear up the delivery instructions before a problem occurs
The product instructs refrigeration for GLP medicine, while the general returns policy says refrigerated products are not currently shipped. Ask the dispenser which instructions apply to the selected preparation and how a questionable arrival is assessed. FDA recommends against using injectable GLP-1 medicine that arrives warm or inadequately refrigerated; the generic policy does not establish an exception. [1] [3] [6]
Boston Medical Group describes itself as a marketplace that connects patients with independent clinicians. [5] Its possible pharmacy list and regulatory descriptions do not independently verify the actual assigned dispenser, license or batch. Compounded medicines are not approved finished brands. I would keep medication evidence separate from the service’s supportive marketing and request the complete prescription details. [2] [4] [6]
Know what cancellation can still change
FAQ says patients are contacted before refill and billing and may cancel through their account. The policy refers to cancellation before shipment and makes prescription sales final once charged payment and carrier handoff have occurred. Obtain the actual renewal date and fulfilment status rather than assume a request reverses a shipment already under way. A disappointing result is not a stated refund guarantee. [2] [3]
Damage should be reported; lost orders are described as eligible for reshipment after carrier-location efforts. No general partial-term cash refund or medical-nonapproval refund timetable is established by the public policy. Terms permit asking to use another pharmacy before ordering, but its price is not guaranteed. My decision would turn on useful support, an exact preparation and a manageable continuing bill. [2] [3] [4]
Understanding the cost
One-month semaglutide $190 and tirzepatide $239. Selected three/six/twelve-month totals are $399/$714/$1,188 and $589/$1,074/$1,788 respectively, with renewal at the selected interval. The lowest $99/$149 monthly equivalents belong to twelve-month plans. [1]
Build your cost estimateSources
- Boston Medical Group: selected semaglutide and tirzepatide plans
- Boston Medical Group: billing, pharmacy, state and cancellation answers
- Boston Medical Group: prescription returns, carrier handoff and loss policy
- Boston Medical Group: served terms last updated October 26, 2023
- Boston Medical Group: current product scope and marketplace role
- FDA: concerns with unapproved GLP-1 drugs, shipping and salt forms
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.